Polyrizon Enrolls First Patient in U.S. Clinical Study of NASARIX (PL-14) Allergy Blocker

GlobeNewswire Inc. | Sep 22, 2026 8:33 AM EDT

First patient marks Polyrizon’s transition into a clinical-stage company.